Group 1 - The report maintains a tactical asset allocation view, recommending an overweight position in A-shares, a neutral position in US Treasuries and gold, and an underweight position in the US dollar [1][11][12] - The report expresses optimism about A-shares due to improved economic outlook, strong government support for capital market development, stable market liquidity, and improving risk appetite [11][12] - The report highlights that the US labor market's cooling has reinforced expectations for a "preventive" easing of monetary policy by the Federal Reserve, with the market fully pricing in a rate cut in September [9][11] Group 2 - The report indicates that multiple factors are likely to support the continued performance of Chinese assets, maintaining a tactical overweight view on A-shares [12][14] - The report notes that the US Treasury market is expected to have a neutral tactical allocation due to the marginal cooling of the US economy and labor market, which has strengthened expectations for easing monetary policy [12][14] - The report suggests that gold prices may benefit from rising geopolitical tensions and adjustments in Federal Reserve monetary policy expectations, maintaining a neutral tactical view on gold [12][14] Group 3 - The report states that the Federal Reserve's expectations for rate cuts are likely to weaken the interest returns on the US dollar, leading to a tactical underweight view on the dollar [13][14] - The report provides a tactical asset allocation summary, indicating an overweight in A-shares, Hong Kong stocks, and US stocks, while maintaining neutral positions in European and Indian equities [14][15] - The report outlines the performance of various asset classes, with A-shares showing a year-to-date increase of 15.48% and a weekly increase of 1.52% [7][21]

Investment Rating - The investment rating for Budweiser APAC is "Buy" [5]. Core Views - The company continues to face performance pressure in the first half of 2025, primarily due to weak demand in China and internal channel adjustments. However, there are signs of improvement in non-immediate consumption channels, while markets like India and South Korea show mixed performance [2][3]. Financial Summary - Total revenue is projected to decline from 6,856 million RMB in 2023 to 5,871 million RMB in 2025, reflecting a decrease of 8.9% in 2024 and 6.0% in 2025. Revenue is expected to recover slightly in 2026 and 2027 [4]. - Gross margin is expected to remain stable, increasing from 50.4% in 2023 to 51.8% by 2027 [4]. - Net profit is forecasted to decrease from 852 million RMB in 2023 to 721 million RMB in 2025, with a slight recovery to 820 million RMB by 2027 [4]. - The price-to-earnings (PE) ratio is projected to be 29.1 in 2023, dropping to 17.5 in 2024, and stabilizing around 17.0 by 2027 [4]. Market Performance - The stock price has fluctuated between 6.94 and 10.82 HKD over the past 52 weeks, with a current market capitalization of 108,596 million HKD [5]. - The company is expected to pay an annual dividend of 5.66 USD (approximately 43.96 HKD), resulting in a dividend yield of about 5.36% based on the current stock price [8]. Earnings Forecast - Earnings per share (EPS) is projected to be 0.05 USD in 2025, with a target price set at 9.74 HKD, corresponding to a PE valuation of approximately 23x for 2025 [8].

Employment Market Overview - The U.S. job market is experiencing a significant slowdown, with non-farm payroll data falling below expectations for two consecutive months, and the three-month moving average of new jobs dropping below 50,000[9] - Initial jobless claims have increased, indicating a rise in the proportion of the underemployed and those finding it difficult to secure jobs, raising concerns about a potential recession[10][14] Labor Supply and Demand Dynamics - The labor market is transitioning from a supply-constrained to a demand-constrained state, with a notable increase in early retirements during the pandemic leading to a labor supply shortage[18] - The balance between labor supply and demand is fragile, with a risk of rapid unemployment rate increases if job demand continues to decline[22] Immigration and Retirement Trends - The impact of immigration on labor supply is diminishing, with net immigration stabilizing and not significantly affecting labor supply[27] - The retirement wave is expected to peak in 2025, with a decrease in the drag on labor supply as the baby boomer generation retires[33] Job Creation and Economic Policy - The estimated monthly job creation needed to maintain the current unemployment rate is between 150,000 and 180,000, while the recent average has been only 120,000[37] - The Federal Reserve may need to adopt a more dovish stance on interest rates, especially if unemployment rate forecasts remain at 4.5%[37] Risks and Considerations - There is a risk of accelerated slowdown in labor demand and a potential resurgence of immigration enforcement policies, which could further impact labor supply[41]

Investment Rating - The industry investment rating is "Increase" for several recommended companies, indicating a potential upside of over 15% relative to the CSI 300 index [12][31]. Core Insights - The textile and apparel industry experienced a decline in export growth in August, with China's textile and apparel exports totaling approximately $26.54 billion, a year-on-year decrease of 5% [16]. - The report highlights the resilience of the sports segment, recommending companies such as Anta Sports, Li Ning, and Xtep International, while also suggesting opportunities in the luxury segment with brands like Prada and Samsonite [12][16]. - The report notes a slowdown in revenue growth for several Taiwanese manufacturers in August, with companies like Yu Yuan and Zhi Qiang reporting declines of 8.80% and 5.48% year-on-year, respectively [16]. Summary by Sections Market Review - The A-share market for the textile and apparel sector rose by 0.67% in the week of September 8-12, 2025, underperforming the CSI 300 index by 0.71 percentage points [6]. - The textile manufacturing sector increased by 1.52%, while the apparel and home textile sector saw a modest rise of 0.21% [6]. Industry Data Tracking - Retail sales for clothing, shoes, and textiles grew by 1.8% in July 2025, while textile and apparel exports fell by 5.05% in August [16][19]. - The report indicates that the inventory-to-sales ratio for U.S. apparel wholesalers increased slightly, suggesting a potential oversupply issue [16]. Recommended Stocks and Valuation - The report provides a detailed valuation forecast for recommended stocks, with Anta Sports projected to have a net profit of 131.8 billion yuan in 2025, and a PE ratio of 18 [12]. - Other recommended stocks include Li Ning, Xtep International, and Prada, all rated for "Increase" with expected growth in net profits over the next few years [12]. Key Announcements and News - Anta announced plans to open 1,000 stores in Southeast Asia over the next three years, indicating strong growth potential in international markets [24]. - H&M opened its first brand experience center in Shanghai, marking a significant step in its retail strategy in China [25].

Investment Rating - The report rates the coal industry as "Overweight" [4]. Core Viewpoints - Coal prices are expected to peak, with pressure remaining in the first half of 2026 but easing compared to the same period in 2025. Demand for electricity coal, combined with the elasticity of coal prices, is likely to lead to prices exceeding 800 RMB/ton in the second half of 2026 [2]. - The report recommends core companies such as China Shenhua, Shaanxi Coal and Chemical Industry, and China Coal Energy, while continuing to recommend Yanzhou Coal Mining and Jincheng Anthracite Mining [4]. Summary by Sections Demand and Supply Analysis - In July, national electricity consumption increased by 8.6% year-on-year, and thermal power generation rose by 4.3%, indicating a significant improvement in the supply-demand balance [4]. - Raw coal production in July was 380 million tons, a decrease of 40 million tons month-on-month, primarily due to extreme weather in Inner Mongolia and Shaanxi [4]. - For the second half of the year, production is expected to decline slightly due to "overproduction checks," with total production projected at 2.35 to 2.4 billion tons, maintaining year-on-year stability [4]. Price Trends - As of September 12, 2025, the price of Q5500 coal at Huanghua Port was 688 RMB/ton, down 3 RMB/ton (-0.4%) from the previous week [7]. - The price of Q5000 coal at Huanghua Port was 595 RMB/ton, down 8 RMB/ton (-1.3%) from the previous week [10]. - The report notes that domestic coal prices are stabilizing while imports continue to decline, leading to an overall downward trend in supply [4]. Focus on Coking Coal - As of September 12, 2025, the price of main coking coal at Jingtang Port was 1550 RMB/ton, unchanged from the previous week [35]. - The average price of metallurgical coke at major domestic ports was 1653 RMB/ton, down 43 RMB/ton (-2.5%) from the previous week [60]. Inventory and Production Rates - As of September 12, 2025, coking coal inventory at three major ports totaled 2.646 million tons, a decrease of 1.6% from the previous week [51]. - The operating rate of coking enterprises with production over 200 million tons was 79.18%, showing a slight increase [4]. Long-term Contracts - The annual long-term contract price for Q5500 coal at Northern Ports was 674 RMB/ton, up 6 RMB/ton (0.9%) month-on-month [33]. - The report indicates that long-term contract prices for coking coal remained stable compared to the previous week [69].

Investment Rating - The report assigns an "Overweight" rating for the military industry [12][38]. Core Viewpoints - The intensification of great power competition is a long-term trend, leading to a favorable long-term outlook for the military industry. The defense strategies of the US and its allies are gradually shifting towards the Indo-Pacific region, which may escalate tensions around China. Increased defense spending is essential to ensure peace, and the military industry is expected to benefit from this trend. The goal of achieving a century of military development by 2027 is anticipated to accelerate during the 14th Five-Year Plan period [2][8]. Summary by Sections Market Review - The military sector has seen an increase, with the defense and military index rising by 2.14%, outperforming the broader market by 0.62 percentage points during the week of September 8-12. The Shanghai Composite Index rose by 1.52%, and the ChiNext Index increased by 2.10% [12][13]. - Among various military indices, the leading military stocks performed the best, with a rise of 2.29%, ranking first among ten indices [12][14]. Major News in the Military Industry - NATO announced the deployment of the "Eastern Sentinel" system to enhance defense posture, integrating military resources from Denmark, France, the UK, and Germany. Concurrently, Russia and Belarus commenced the "West-2025" joint strategic exercise, aimed at improving military coordination and operational capabilities [9][10][23][25]. - The report highlights significant domestic and international military news, including China's maritime patrols and military exercises, as well as developments in the Israeli military operations [23][24]. Investment Recommendations - Recommended stocks include: 1. Assembly: AVIC Shenyang Aircraft Company (中航沈飞), AVIC Xi'an Aircraft Industry Group (中航西飞) 2. Components: AVIC Optoelectronics (中航光电) 3. Subsystems: AVIC Onboard (中航机载), North Navigation (北方导航), Aerospace Nanhai (航天南湖) 4. Materials and Processing: Philihua (菲利华), Huayin Technology (华秦科技) [10][11].

Investment Rating - The industry investment rating is "Overweight" [6] Core Insights - The report emphasizes the importance of monitoring short-term pig prices and long-term production capacity policies in the pig farming sector [3][12] - In the pet industry, attention is drawn to the top-ranked brands on platforms like Douyin, indicating a shift towards health-focused innovations [4] - The planting sector is highlighted with a focus on the upcoming harvest and the performance of corn varieties under extreme weather conditions [5] Summary by Sections Pig Farming - The report suggests paying attention to the fluctuations in pig prices and the impact of production capacity policies on the industry [3][12] - Recent data shows that the average pig price is 14.10 yuan/kg, reflecting a decrease of 1.25% week-on-week and a significant year-on-year decline of 28.16% [11] Pet Industry - The top three brands in the pet category on Douyin are Maifudi, Weishi, and Frigat, with a notable focus on health-oriented product innovations [4] Planting Sector - As the harvest season approaches, the report advises monitoring the grain yield, particularly corn and wheat prices, which have seen slight increases [5] - Special crops like blueberries and peppers are also highlighted, with attention to the cost changes of raw materials for companies like Chenguang Biological [5] Investment Recommendations - Recommended stocks in the pig farming sector include Muyuan Foods and Wens Foodstuffs [5] - Other recommended stocks across various sectors include Morning Light Biological, Longping High-Tech, and Petty Holdings in the pet sector [5][41]

Investment Rating - The report maintains an "Overweight" rating for the overseas technology sector [1][4]. Core Insights - Oracle's RPO surged significantly, leading to a substantial upward revision of cloud revenue guidance, with visibility extending to 2030. The RPO reached $455 billion as of FY26Q1, including a $300 billion contract with OpenAI, reflecting a quarter-over-quarter increase of $317 billion. The AI infrastructure remains in high demand, with expectations of signing more multi-billion dollar contracts, potentially increasing RPO to over $500 billion [3][8]. - NVIDIA introduced the Rubin CPX inference chip, which significantly enhances inference efficiency, particularly for applications requiring long context windows. The chip is expected to be available by the end of 2026, with performance improvements of up to 6.5 times compared to current flagship systems [9][10]. - The iPhone 17 series was launched with notable upgrades, including a new A19 chip and enhanced camera systems, maintaining competitive pricing [10]. Summary by Sections Weekly Overview - Oracle's RPO increase and AI industry trends indicate a sustained high growth outlook through 2030, with significant investments from major players like Meta and Microsoft in AI infrastructure [8]. Investment Recommendations - Recommended sectors include AI computing (NVIDIA, TSMC), cloud providers (Microsoft, Amazon, Google, Meta), AI applications (Apple, Qualcomm), AI social networks (Tencent, Meta), and Chinese companies benefiting from AI cycles (Pinduoduo, Meituan, JD.com, NetEase) [27][28].

Investment Rating - The report assigns an "Overweight" rating to the food and beverage industry [1] Core Insights - The food and beverage sector is experiencing cyclical opportunities due to supply and demand clearing, with performance advantages evident in beverages, snacks, and raw materials. The financials of the liquor sector are improving, particularly for Moutai [3][4] Summary by Sections Investment Recommendations - The report suggests increasing holdings in growth stocks within beverages, snacks, and food sectors, highlighting the performance advantages. It recommends overweight positions in elastic liquor stocks such as Hong Kong-listed Zhenjiu Lidu, Shede Liquor, Shanxi Fenjiu, Luzhou Laojiao, and Jiu Gui Jiu. For stable mid-term holdings, it suggests Wuliangye, Guizhou Moutai, Yingjia Gongjiu, Jianshiyuan, and Guqingongjiu. In the beverage sector, it recommends increasing positions in leading companies like Dongpeng Beverage and Chengde Lulou, as well as Hong Kong-listed Nongfu Spring, Master Kong Holdings, and China Resources Beverage. For snacks and food raw materials, it suggests increasing holdings in Bailong Chuangyuan, Yanjinpuzi, Three Squirrels, and Ximai Foods, along with Hong Kong-listed Weilong Delicious. In the beer segment, it recommends increasing positions in Tsingtao Brewery, Zhujiang Brewery, and Bai Run Shares, as well as Hong Kong-listed China Resources Beer. For condiments and livestock, it suggests increasing holdings in Yili Group, New Dairy, Youran Livestock, Modern Farming, Baoli Foods, and Haitian Flavoring [8][9] Liquor Sector - The liquor sector is seeing a clearing of financials, with Moutai showing signs of improved sales. In Q2 2025, high-end, sub-high-end, and regional liquor revenues grew by 3%, declined by 5%, and decreased by 27% year-on-year, respectively. Net profits for these categories also showed a similar trend. The consumption environment is suppressing industry demand, leading to accelerated inventory reduction. Moutai's official data indicates a recovery in terminal sales as traditional festivals approach, with significant month-on-month growth observed since late August. The company emphasizes sustainable high-quality development, which may alleviate supply-demand conflicts and support pricing [9][10] Consumer Goods Sector - The consumer goods sector is characterized by structural growth, with beverages performing well, stable beer sales, and significant differentiation in snacks. The leading companies in condiments are showing advantages, while dairy products are experiencing marginal improvements. The report suggests that new consumer leaders in food additives, health products, beverages, and snacks have potential for future growth, driven by innovation and management strategies that could widen the gap with competitors [11]

Investment Rating - The investment rating for the company is "Accumulate" with a target price of 40.12 CNY [7][12]. Core Views - The company's core CHC segment performance has been under pressure due to a decrease in flu incidence and channel adjustments, but its leading brand position in the traditional Chinese medicine OTC sector remains intact, indicating potential for sustained growth through both organic and external drivers [2][12]. - The company reported a revenue of 14.81 billion CNY for the first half of 2025, a year-on-year increase of 4.99%, while the net profit attributable to the parent company was 1.815 billion CNY, a decline of 24.31% [12]. - The company completed the consolidation of Tianshili, a traditional Chinese medicine innovative drug enterprise, enhancing its competitive edge in the innovative Chinese medicine sector [12]. Financial Summary - Total revenue projections are as follows: 24,739 million CNY for 2023, 27,617 million CNY for 2024, 30,418 million CNY for 2025, 32,406 million CNY for 2026, and 34,504 million CNY for 2027, reflecting growth rates of 36.8%, 11.6%, 10.1%, 6.5%, and 6.5% respectively [5][13]. - Net profit attributable to the parent company is projected to be 2,853 million CNY for 2023, 3,368 million CNY for 2024, 3,423 million CNY for 2025, 3,818 million CNY for 2026, and 4,287 million CNY for 2027, with growth rates of 16.5%, 18.1%, 1.6%, 11.5%, and 12.3% respectively [5][13]. - The earnings per share (EPS) estimates are 1.71 CNY for 2023, 2.02 CNY for 2024, 2.06 CNY for 2025, 2.29 CNY for 2026, and 2.58 CNY for 2027 [5][13]. Market Performance - The company's stock price has shown a 52-week range of 29.25 CNY to 51.82 CNY, with a current price of 29.50 CNY [8][12]. - The total market capitalization is approximately 49,096 million CNY [8]. Business Segments - The CHC business revenue for the first half of 2025 was 6.08 billion CNY, a year-on-year decrease of 18.4%, while the prescription drug revenue was 2.78 billion CNY, reflecting a growth of 15.2% [12]. - The gross margin for the CHC business was 59.9%, down by 2.43 percentage points year-on-year, while the gross margin for prescription drugs increased by 1.89 percentage points to 49.0% [12]. Research and Development - The company continues to invest in R&D, with notable projects including a joint development project for HiCM-188, which is the first innovative drug for heart failure regeneration therapy approved for clinical use in both China and the U.S. [12]. - A collaboration with Borui Pharmaceutical for a dual-target weight loss drug BGM0504 is also underway, with the product currently in Phase III clinical trials [12].